130 related articles for article (PubMed ID: 37119639)
21. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
[TBL] [Abstract][Full Text] [Related]
22. Prognostic impact of additive chemotherapy after curative resection of metachronous colorectal liver metastasis: a single-centre retrospective study.
Kelm M; Schollbach J; Anger F; Wiegering A; Klein I; Germer CT; Schlegel N; Kunzmann V; Löb S
BMC Cancer; 2021 May; 21(1):490. PubMed ID: 33941104
[TBL] [Abstract][Full Text] [Related]
23. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases.
Hammill CW; Billingsley KG; Cassera MA; Wolf RF; Ujiki MB; Hansen PD
Ann Surg Oncol; 2011 Jul; 18(7):1947-54. PubMed ID: 21399885
[TBL] [Abstract][Full Text] [Related]
24. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
[TBL] [Abstract][Full Text] [Related]
25. Survival after combined resection and ablation is not inferior to that after resection alone, in patients with four or more colorectal liver metastases.
Amygdalos I; Hitpass L; Schmidt F; Josephs G; Bednarsch J; Berres ML; Lüdde T; Olde Damink SWM; Ulmer TF; Neumann UP; Bruners P; Lang SA
Langenbecks Arch Surg; 2023 Aug; 408(1):343. PubMed ID: 37642753
[TBL] [Abstract][Full Text] [Related]
26. Local Tumour Control Following Microwave Ablation: Protocol for the Prospective Observational CIEMAR Study.
Pereira PL; Bale R; Fretland ÅA; Goldberg SN; Helmberger T; Meijerink MR; Orsi F; Stättner S; Vogl T; Kafkoula A; de Jong N; Zeka B; de Baère T
Cardiovasc Intervent Radiol; 2024 Jan; 47(1):121-129. PubMed ID: 37884801
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of Rehepatectomy for Colorectal Liver Metastases: A Contemporary Multi-Institutional Analysis from the French Surgical Association Database.
Hallet J; Cunha AS; Adam R; Goéré D; Azoulay D; Mabrut JY; Muscari F; Laurent C; Navarro F; Pessaux P;
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):894-903. PubMed ID: 27573524
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases.
Ko S; Jo H; Yun S; Park E; Kim S; Seo HI
World J Gastroenterol; 2014 Jan; 20(2):525-31. PubMed ID: 24574721
[TBL] [Abstract][Full Text] [Related]
30. Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy.
Buisman FE; Filipe WF; Kemeny NE; Narayan RR; Srouji RM; Balachandran VP; Boerner T; Drebin JA; Jarnagin WR; Kingham TP; Wei AC; Grünhagen DJ; Verhoef C; Koerkamp BG; D'Angelica MI
Ann Surg Oncol; 2021 Feb; 28(2):808-816. PubMed ID: 32648182
[TBL] [Abstract][Full Text] [Related]
31. The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival.
Höppener DJ; Nierop PMH; van Amerongen MJ; Olthof PB; Galjart B; van Gulik TM; de Wilt JHW; Grünhagen DJ; Rahbari NN; Verhoef C
Ann Surg Oncol; 2019 Sep; 26(9):2812-2820. PubMed ID: 31147988
[TBL] [Abstract][Full Text] [Related]
32. A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases.
Chun YJ; Kim SG; Lee KW; Cho SH; Kim TW; Baek JY; Park YS; Hong S; Chu CW; Beom SH; Jung M; Shin SJ; Ahn JB
Clin Colorectal Cancer; 2020 Sep; 19(3):e140-e150. PubMed ID: 32402681
[TBL] [Abstract][Full Text] [Related]
33. Long-term and perioperative outcomes of laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study.
Beppu T; Wakabayashi G; Hasegawa K; Gotohda N; Mizuguchi T; Takahashi Y; Hirokawa F; Taniai N; Watanabe M; Katou M; Nagano H; Honda G; Baba H; Kokudo N; Konishi M; Hirata K; Yamamoto M; Uchiyama K; Uchida E; Kusachi S; Kubota K; Mori M; Takahashi K; Kikuchi K; Miyata H; Takahara T; Nakamura M; Kaneko H; Yamaue H; Miyazaki M; Takada T
J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):711-20. PubMed ID: 25902703
[TBL] [Abstract][Full Text] [Related]
34. Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
Dupré A; Jones RP; Diaz-Nieto R; Fenwick SW; Poston GJ; Malik HZ
Eur J Surg Oncol; 2017 Oct; 43(10):1901-1907. PubMed ID: 28888801
[TBL] [Abstract][Full Text] [Related]
35. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
[TBL] [Abstract][Full Text] [Related]
36. Benefits of Laparoscopic Approach for Resection of Liver Tumors in Cirrhotic Patients.
Le Roux F; Rebibo L; Cosse C; Chatelain D; Nguyen-Khac E; Badaoui R; Regimbeau JM
J Laparoendosc Adv Surg Tech A; 2018 May; 28(5):553-561. PubMed ID: 29350570
[TBL] [Abstract][Full Text] [Related]
37. Survival Evidence of Local Control for Colorectal Cancer Liver Metastases by Hepatectomy and/or Radiofrequency Ablation.
Canseco LM; Liu YW; Lu CC; Lee KC; Chen HH; Hu WH; Tsai KL; Yang YH; Wang CC; Hung CH
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760404
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
[TBL] [Abstract][Full Text] [Related]
39. Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience.
Stättner S; Primavesi F; Yip VS; Jones RP; Öfner D; Malik HZ; Fenwick SW; Poston GJ
Surg Today; 2015 Apr; 45(4):407-15. PubMed ID: 24633931
[TBL] [Abstract][Full Text] [Related]
40. Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver.
Tanaka K; Shimada H; Nagano Y; Endo I; Sekido H; Togo S
Surgery; 2006 Feb; 139(2):263-73. PubMed ID: 16455336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]